• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4623447)   Today's Articles (1848)   Subscriber (49408)
For: Torvik D, Madsbu HP. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension. Br J Clin Pharmacol 1986;21 Suppl 1:69S-75S. [PMID: 2939870 PMCID: PMC1400760 DOI: 10.1111/j.1365-2125.1986.tb02856.x] [Citation(s) in RCA: 50] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]  Open
Number Cited by Other Article(s)
1
Sarkar M, Nath A, Kumer A, Mallik C, Akter F, Moniruzzaman M, Ali M. Synthesis, molecular docking screening, ADMET and dynamics studies of synthesized 4-(4-methoxyphenyl)-8-methyl-3,4,5,6,7,8-hexahydroquinazolin-2(1H)-one and quinazolinone derivatives. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2021.130953] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
2
Alkozi HA, Navarro G, Aguinaga D, Reyes-Resina I, Sanchez-Naves J, Pérez de Lara MJ, Franco R, Pintor J. Adreno-melatonin receptor complexes control ion homeostasis and intraocular pressure - their disruption contributes to hypertensive glaucoma. Br J Pharmacol 2020;177:2090-2105. [PMID: 31901203 DOI: 10.1111/bph.14971] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2019] [Revised: 12/05/2019] [Accepted: 12/09/2019] [Indexed: 12/24/2022]  Open
3
McComb MN, Chao JY, Ng TMH. Direct Vasodilators and Sympatholytic Agents. J Cardiovasc Pharmacol Ther 2015;21:3-19. [PMID: 26033778 DOI: 10.1177/1074248415587969] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/10/2014] [Accepted: 03/31/2015] [Indexed: 11/16/2022]
4
Rieckert H, Weidinger G, Schardt FW. Orthostatic Hypotension during Antihypertensive Treatment with Bunazosin and Prazosin. Clin Drug Investig 2012. [DOI: 10.1007/bf03259240] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
5
The Effects of Food on the Oral Bioavailability of Doxazosin in Hypertensive Subjects. ACTA ACUST UNITED AC 2012. [DOI: 10.1007/bf03258458] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
6
Heran BS, Galm BP, Wright JM. Blood pressure lowering efficacy of alpha blockers for primary hypertension. Cochrane Database Syst Rev 2012;2012:CD004643. [PMID: 22895943 PMCID: PMC11337167 DOI: 10.1002/14651858.cd004643.pub3] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
7
Heran BS, Galm BP, Wright JM. Blood pressure lowering efficacy of alpha blockers for primary hypertension. Cochrane Database Syst Rev 2009:CD004643. [PMID: 19821331 DOI: 10.1002/14651858.cd004643.pub2] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
8
Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol 2009;104:270-5. [PMID: 19576359 DOI: 10.1016/j.amjcard.2009.03.030] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2009] [Revised: 03/13/2009] [Accepted: 03/13/2009] [Indexed: 11/23/2022]
9
Hjortdahl P, von Krogh H, Daae L, Holme I, Hjermann I. A 24-week multicenter double-blind study of doxazosin and hydrochlorothiazide in patients with mild to moderate essential hypertension. ACTA MEDICA SCANDINAVICA 2009;221:427-34. [PMID: 2955672 DOI: 10.1111/j.0954-6820.1987.tb01276.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
10
Wykretowicz A, Guzik P, Wysocki H. Doxazosin in the current treatment of hypertension. Expert Opin Pharmacother 2008;9:625-33. [DOI: 10.1517/14656566.9.4.625] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
11
Bryson CL, Psaty BM. A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy. CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE 2002;3:7. [PMID: 12097149 PMCID: PMC134479 DOI: 10.1186/1468-6708-3-7] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 01/18/2002] [Accepted: 04/12/2002] [Indexed: 01/13/2023]
12
Simonsen U, Prieto D, Nyborg NC, Mulvany MJ. Effects of doxazosin on functional alterations of isolated coronary arteries from cholesterol-fed rabbits. J Pharm Pharmacol 1996;48:607-14. [PMID: 8832495 DOI: 10.1111/j.2042-7158.1996.tb05982.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
13
Fulton B, Wagstaff AJ, Sorkin EM. Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia. Drugs 1995;49:295-320. [PMID: 7537194 DOI: 10.2165/00003495-199549020-00011] [Citation(s) in RCA: 128] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
14
Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994;331:394-8. [PMID: 8028622 DOI: 10.1056/nejm199408113310611] [Citation(s) in RCA: 451] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
15
Harper KJ, Forker AD. Antihypertensive therapy. Postgrad Med 1992;91:163-6, 171-4, 179-86 passim. [PMID: 1349744 DOI: 10.1080/00325481.1992.11701321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
16
Lehtonen A. Doxazosin effects on insulin and glucose in hypertensive patients. The Finnish Multicenter Study Group. Am Heart J 1991;121:1307-11. [PMID: 1826187 DOI: 10.1016/0002-8703(91)90438-n] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
17
Rey AM, Grauer K, Gums JG. Newer antihypertensive agents. Postgrad Med 1991;89:75-81, 84, 89. [PMID: 2008405 DOI: 10.1080/00325481.1991.11700892] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
18
Hunninghake DB. Effects of celiprolol and other antihypertensive agents on serum lipids and lipoproteins. Am Heart J 1991;121:696-701. [PMID: 1671189 DOI: 10.1016/0002-8703(91)90449-r] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
19
Silva H, Fonseca R, Marshall D. Doxazosin in the treatment of essential hypertension in general medical practice in Latin America. Am Heart J 1991;121:329-35. [PMID: 1824656 DOI: 10.1016/0002-8703(91)90867-h] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
20
Englert RG, Barlage U. The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by beta-blockers. Am Heart J 1991;121:311-6. [PMID: 1670745 DOI: 10.1016/0002-8703(91)90864-e] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
21
Harmse DP. Clinical experience with doxazosin in general medical practice in The Netherlands. Am Heart J 1991;121:341-5. [PMID: 1824658 DOI: 10.1016/0002-8703(91)90869-j] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
22
Pool JL. Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism. Am Heart J 1991;121:251-9; discussion 259-60. [PMID: 1824647 DOI: 10.1016/0002-8703(91)90853-a] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
23
Holme I, Fauchald P, Rugstad HE, Stokke HP. Preliminary results of the Norwegian doxazosin postmarketing surveillance study: a twelve-week experience. Am Heart J 1991;121:260-7. [PMID: 1824648 DOI: 10.1016/0002-8703(91)90855-c] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
24
Wessels F. Double-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension. Am Heart J 1991;121:299-303. [PMID: 1824653 DOI: 10.1016/0002-8703(91)90862-c] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
25
Hernandez Hernandez R, Guerrero Pajuelo JR, Carvajal AR, Armas Padilla MC, Armas de Hernandez MJ, Barragan O, Boada Boada JJ. Evidence of an antiplatelet aggregation action of doxazosin in patients with hypertension: an ex vivo study. Am Heart J 1991;121:395-401. [PMID: 1824666 DOI: 10.1016/0002-8703(91)90878-l] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
26
Brinchmann-Hansen O, Christensen CC, Myhre K. The response of the light reflex of retinal vessels to reduced blood pressure in hypertensive patients. Acta Ophthalmol 1990;68:155-61. [PMID: 2192529 DOI: 10.1111/j.1755-3768.1990.tb01897.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
27
Pool JL, Taylor AA, Nelson EB. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension. Am J Med 1989;87:57S-61S. [PMID: 2569825 DOI: 10.1016/0002-9343(89)90115-0] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
28
Ames RP, Chrysant SG, Gonzalez F, Schnaper HW, Spann S, Velasquez MT. Effectiveness of doxazosin in systemic hypertension. Am J Cardiol 1989;64:203-8. [PMID: 2525870 DOI: 10.1016/0002-9149(89)90458-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
29
Johnson BF, Danylchuk MA. The relevance of plasma lipid changes with cardiovascular drug therapy. Med Clin North Am 1989;73:449-73. [PMID: 2645483 DOI: 10.1016/s0025-7125(16)30682-4] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
30
Ames RP, Kiyasu JY. Alpha-1 adrenoceptor blockade with doxazosin in hypertension: effects on blood pressure and lipoproteins. J Clin Pharmacol 1989;29:123-7. [PMID: 2565917 DOI: 10.1002/j.1552-4604.1989.tb03299.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
31
Talseth T, Westlie L, Daae L, Vatle S. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients. Am Heart J 1988;116:1790-6. [PMID: 2904752 DOI: 10.1016/0002-8703(88)90231-1] [Citation(s) in RCA: 29] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
32
Lindner UK, von Manteuffel GE, Stafunsky M. The addition of doxazosin to the treatment regimen of hypertensive patients not responsive to nifedipine. Am Heart J 1988;116:1814-20. [PMID: 2904756 DOI: 10.1016/0002-8703(88)90235-9] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
33
Englert RG, Mauersberger H. A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy. Am Heart J 1988;116:1826-32. [PMID: 2904758 DOI: 10.1016/0002-8703(88)90237-2] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
34
van den Hogen AL. Doxazosin in the treatment of mild and moderate essential hypertension in general medical practice. Am Heart J 1988;116:1757-62. [PMID: 2904746 DOI: 10.1016/0002-8703(88)90225-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
35
Taylor SH, Lee PS, Sharma SK. A comparison of doxazosin and enalapril in the treatment of mild and moderate essential hypertension. Am Heart J 1988;116:1820-5. [PMID: 2904757 DOI: 10.1016/0002-8703(88)90236-0] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
36
Bartels AC, de Vries PM, Oe LP, van Bronswÿk H, Donker AJ, Réveillaud RJ, Fillastre JP, Zech P. Doxazosin in the treatment of patients with mild or moderate hypertension and mild or moderate renal insufficiency. Am Heart J 1988;116:1772-7. [PMID: 2904749 DOI: 10.1016/0002-8703(88)90228-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
37
Cubeddu LX. New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance. Am Heart J 1988;116:133-62. [PMID: 2899387 DOI: 10.1016/0002-8703(88)90261-x] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
38
Leren TP, Berg K. Studies of serum lipids in hypercholesterolaemic rabbits treated with doxazosin. Scand J Clin Lab Invest 1988;48:313-7. [PMID: 2907180 DOI: 10.3109/00365518809167501] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
39
Young RA, Brogden RN. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension. Drugs 1988;35:525-41. [PMID: 2899495 DOI: 10.2165/00003495-198835050-00003] [Citation(s) in RCA: 70] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
40
Smyth P, Pringle S, Jackson G, Lorimer AR. 24-hour control of blood pressure by once daily doxazosin: a multicentre double-blind comparison with placebo. Eur J Clin Pharmacol 1988;34:613-8. [PMID: 2971549 DOI: 10.1007/bf00615226] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
41
Weidmann P, Ferrier C, Saxenhofer H, Uehlinger DE, Trost BN. Serum lipoproteins during treatment with antihypertensive drugs. Drugs 1988;35 Suppl 6:118-34. [PMID: 3042351 DOI: 10.2165/00003495-198800356-00017] [Citation(s) in RCA: 57] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
42
Scott PJ, Hosie J, Scott MG. A double-blind and cross-over comparison of once daily doxazosin and placebo with steady-state pharmacokinetics in elderly hypertensive patients. Eur J Clin Pharmacol 1988;34:119-23. [PMID: 2968267 DOI: 10.1007/bf00614546] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
43
Ames RP. The influence of non-beta-blocking drugs on the lipid profile: are diuretics outclassed as initial therapy for hypertension? Am Heart J 1987;114:998-1006. [PMID: 2889346 DOI: 10.1016/0002-8703(87)90599-0] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
44
Rosenthal J. A multicenter trial of doxazosin in West Germany. Am J Cardiol 1987;59:40G-45G. [PMID: 2884852 DOI: 10.1016/0002-9149(87)90156-1] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
45
Trost BN, Weidmann P, Riesen W, Claessens J, Streulens Y, Nelemans F. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension. Am J Cardiol 1987;59:99G-104G. [PMID: 2884861 DOI: 10.1016/0002-9149(87)90167-6] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
46
Torvik D, Madsbu HP. An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension. Am J Cardiol 1987;59:68G-72G. [PMID: 2884855 DOI: 10.1016/0002-9149(87)90160-3] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
47
Ott P, Storm TL, Krusell LR, Jensen H, Badskjaer J, Faergeman O. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension. Am J Cardiol 1987;59:73G-77G. [PMID: 2884856 DOI: 10.1016/0002-9149(87)90161-5] [Citation(s) in RCA: 28] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
48
Ames RP. The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs. Drugs 1986;32:335-57. [PMID: 2877846 DOI: 10.2165/00003495-198632040-00003] [Citation(s) in RCA: 78] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
49
Cox DA, Leader JP, Milson JA, Singleton W. The antihypertensive effects of doxazosin: a clinical overview. Br J Clin Pharmacol 1986;21 Suppl 1:83S-90S. [PMID: 2939872 PMCID: PMC1400750 DOI: 10.1111/j.1365-2125.1986.tb02858.x] [Citation(s) in RCA: 47] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA